Completion of All Implants in the ReActiv8-B US IDE Clinical Study

Mainstay Medical Announces the Completion of All Implants in the ReActiv8-B Study

July 09, 2018 DUBLIN–(BUSINESS WIRE)–Regulatory News: Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and Euronext Dublin: MSTY.IE),…